Les groupes de patients et les conflits d'intérêts (NEJM, 02/03/2017) Conflicts of Interest for Patient-Advocacy Organizations In this examination of 104 large patient-advocacy organizations, 83% receive financial support from drug, device, and biotechnology companies, and industry executives often serve on governing boards. The authors recommend more transparency about industry involvement
In Québec, in Canada and elsewhere in the world, expert advisory committees advise and guide govern...
Objective: To investigate pharmaceutical or medical device industry funding of patient groups. Desig...
Background: There is extensive and varied interaction between the pharmaceutical industry and the me...
National audienceINTRODUCTION: Since 1995, disclosure of conflicts of interest in international scie...
Étude de cas / Case studyCertains groupes de défense des patients et autres groupes de pression dans...
Transparency has become one of the primary themes in health care reform efforts in the United States...
International audienceThe handling of conflicts of interest in the area of healthcare products and t...
tical industry. All of the CPG authors who had industry rela-tionships had financial relationships w...
Financial conflicts of interest (FCOIs) could bias the potentially practice-changing oncologic rando...
The handling of conflicts of interest in the area of healthcare products and technology ha...
In France, as in other countries, the issue of conflict of interest became increasingly salient duri...
A conflict of interest is a delicate situation where a person with a confidence role like a physicia...
Aujourd hui, les interactions entre l industrie pharmaceutique et les professionnels de santé sont a...
Pharmaceutical industry funding of patient organizations raises ethical challenges related to patien...
Objective To describe how Italian medical societies interact with pharmaceutical and medical device ...
In Québec, in Canada and elsewhere in the world, expert advisory committees advise and guide govern...
Objective: To investigate pharmaceutical or medical device industry funding of patient groups. Desig...
Background: There is extensive and varied interaction between the pharmaceutical industry and the me...
National audienceINTRODUCTION: Since 1995, disclosure of conflicts of interest in international scie...
Étude de cas / Case studyCertains groupes de défense des patients et autres groupes de pression dans...
Transparency has become one of the primary themes in health care reform efforts in the United States...
International audienceThe handling of conflicts of interest in the area of healthcare products and t...
tical industry. All of the CPG authors who had industry rela-tionships had financial relationships w...
Financial conflicts of interest (FCOIs) could bias the potentially practice-changing oncologic rando...
The handling of conflicts of interest in the area of healthcare products and technology ha...
In France, as in other countries, the issue of conflict of interest became increasingly salient duri...
A conflict of interest is a delicate situation where a person with a confidence role like a physicia...
Aujourd hui, les interactions entre l industrie pharmaceutique et les professionnels de santé sont a...
Pharmaceutical industry funding of patient organizations raises ethical challenges related to patien...
Objective To describe how Italian medical societies interact with pharmaceutical and medical device ...
In Québec, in Canada and elsewhere in the world, expert advisory committees advise and guide govern...
Objective: To investigate pharmaceutical or medical device industry funding of patient groups. Desig...
Background: There is extensive and varied interaction between the pharmaceutical industry and the me...